Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications
Top Cited Papers
Open Access
- 15 July 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (2) , 618-621
- https://doi.org/10.1182/blood-2005-10-4184
Abstract
Natural killer T (NKT) cells are CD1d-restricted glycolipid reactive innate lymphocytes that play an important role in protection from pathogens and tumors. PhaKeywords
This publication has 24 references indexed in Scilit:
- Regulation of hematopoiesis in vitro and in vivo by invariant NKT cellsBlood, 2006
- Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patientsThe Journal of Experimental Medicine, 2005
- TOWARD AN UNDERSTANDING OF NKT CELL BIOLOGY: Progress and ParadoxesAnnual Review of Immunology, 2005
- Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical applicationBritish Journal of Haematology, 2004
- The evolution of thalidomide and its IMiD derivatives as anticancer agentsNature Reviews Cancer, 2004
- Immunomodulatory drug costimulates T cells via the B7-CD28 pathwayBlood, 2004
- Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered ProteinThe Journal of Experimental Medicine, 2003
- Sequential production of interferon-γ by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramideBlood, 2002
- Selective induction of NK cell proliferation and cytotoxicity by activated NKT cellsEuropean Journal of Immunology, 2000
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999